Table 4.
Site-wise lesions and complications in eyes among the patients with mpox.
| Number of Studies | Pooled Prevalence ES | 95% CI | |
|---|---|---|---|
| Manifestations | |||
| Conjunctivitis | 6 * | 13.89% | 6.92–22.67 |
| Conjunctival ulceration | 1 | 2.13% | 0.38–11.11 |
| Conjunctival lesion (unspecified) | 2 | 1.62% | 0.80–2.69 |
| Eye rash (location unspecified) | 2 | 14.37% | 6.91–23.71 |
| Pustules or pseudo-pustules in eyelid | 1 | 1.08% | 0.30–3.86 |
| Redness, pain, and discharge | 1 | 9.26% | 6.07–13.87 |
| Complications | |||
| Photophobia | 2 | 30.87% | 28.13–33.67 |
| Keratitis/Corneal ulceration | 3 | 3.33% | 1.99–4.95 |
| Corneal opacity | 1 | 38.1% | 20.75–59.12 |
| blindness (Unilateral/Bilateral) | 1 | 7.69% | 5.30–11.03 |
* I2 = 94.62%, p < 0.001.